Results 211 to 220 of about 7,397 (255)
Some of the next articles are maybe not open access.
Journal of the American Academy of Dermatology, 1991
Multiple exostoses syndrome (MES) is a inheritable disorder that affects the enchondral skeleton during growth. It is characterized by thickening and deformity of the growing bone with the formation of numerous cartilage-capped exostoses clustered around areas of most active ...
R, Baran, H, Bureau
openaire +2 more sources
Multiple exostoses syndrome (MES) is a inheritable disorder that affects the enchondral skeleton during growth. It is characterized by thickening and deformity of the growing bone with the formation of numerous cartilage-capped exostoses clustered around areas of most active ...
R, Baran, H, Bureau
openaire +2 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2000
Multiple exostoses is a hereditary disease characterized by multiple osteocartilagenous tumors, of which the histological structures are similar to those of normal epiphyses. Genetic linkage has identified three different loci for this disease: EXT1 on 8q, EXT2 on 11p, and EXT3 on 19p.
J, Toguchida, S, Nagayama
openaire +1 more source
Multiple exostoses is a hereditary disease characterized by multiple osteocartilagenous tumors, of which the histological structures are similar to those of normal epiphyses. Genetic linkage has identified three different loci for this disease: EXT1 on 8q, EXT2 on 11p, and EXT3 on 19p.
J, Toguchida, S, Nagayama
openaire +1 more source
Multiple Hereditary Exostoses.
Radiologic technology, 2016Multiple hereditary exostoses (MHE), also known as multiple osteochondromas, is an autosomal dominant disease that results in the development of osteochondromas throughout the body. The disease typically is diagnosed during childhood and requires lifelong monitoring and treatment of painful osteochondromas.
openaire +3 more sources
Multiple Exostoses Complicating Pregnancy
American Journal of Obstetrics and Gynecology, 1955D J, LEAHY, P, STEINHORN
openaire +2 more sources
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly
Genetic testing in prostate cancer management: Considerations informing primary care
Ca-A Cancer Journal for Clinicians, 2022Veda N Giri +2 more
exaly

